Retrophin, Inc. (RTRX): Hedge Funds Are Crazy About This Fallen Angel

Retrophin, Inc. (NASDAQ:RTRX) shares were trading as high as $37 last summer but like most small-cap biotech stocks lost a large chunk of its value since then.

Keep Reading →